Single-cell profiling reveals a novel CAF subpopulation linking stromal heterogeneity to immune suppression in breast cancer subtypes
View Full Paper
Ask AI
Bookmark
Share
Key Points
This research aims to characterize the diverse roles of cancer-associated fibroblasts (CAFs) in breast cancer subtypes, focusing on immune suppression and treatment outcomes.
Integrated three single-cell RNA sequencing datasets from 29 breast cancer patients.
Analyzed bulk RNA-seq data from The Cancer Genome Atlas (TCGA) to examine CAF subsets and immune interactions.
Identified a novel CAF subset, msCAF, through gene signature analysis related to immune suppression and chemotherapy response.
Identified four stromal populations, including a novel CAF subset, msCAF, associated with immune suppression.
msCAF abundance inversely correlated with T-cell function, particularly in triple negative breast cancer (TNBC) environments.
msCAF gene signatures predicted chemotherapy response, with distinct prognostic relevance for Luminal A and TNBC tumors.
Discussion
No takes yet. Share an insight, caveat, or question.
Implication
Randomized trial reveals a novel CAF subpopulation affecting immune response in breast cancer, suggesting new treatment strategies.